Table 3.
Severe acute sickle-cell complications and its generated factors treatment cost.
| Diagnostic | n | % | Global management care XAF (USD) |
p value |
|---|---|---|---|---|
| Major acute pain + bacterial infections | 12 | 12.8 | 66,765 (117.50) | |
|
| ||||
| Hyperhemolysis + bacterial infections | 18 | 19.2 | 103,492 (182.14) | p = 0.041 |
|
| ||||
| Mixed severe acute crisis + bacterial infections | 28 | 29.8 | 135,271 (238.07) | |
|
| ||||
| Major acute pain + malaria | 4 | 4.2 | 28,305 (49.82) | |
|
| ||||
| Hyperhemolysis + malaria | 16 | 17,1 | 64,891.63 (114.21) | |
|
| ||||
| Mixed severe acute crisis + malaria | 8 | 8.5 | 99,944 (175.90) | |
|
| ||||
| Major acute pain + acute chest syndrome | 2 | 2.1 | 42,800 (75.33) | |
|
| ||||
| Hyperhemolysis + acute chest syndrome | 2 | 2.1 | 62,800 (110.52) | |
|
| ||||
| Mixed severe acute crisis + stroke | 4 | 4.2 | 130,333 (229.38) | |
|
| ||||
| Total | 94 | 100 | ||